Transcription of LAMISIL ONCE 1 % CUTANEOUS SOLUTION PL …
{{id}} {{{paragraph}}}
Example: tourism industry
LAMISIL ONCE 1 % CUTANEOUS SOLUTION PL …
MHRA PAR LAMISIL Once 1 % CUTANEOUS SOLUTION PL 00030/0213 1 LAMISIL ONCE 1 % CUTANEOUS SOLUTION PL 00030/0213 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 32 Summary of product characteristics Page 33 Product information leaflet Page 39 Labelling Page 41 LAMISIL ONCE 1 % CUTANEOUS SOLUTION and PL 00030/0213 LAY SUMMARY The MHRA today granted Novartis Consumer Health Ltd Marketing Authorisations (licences) for the medicinal products LAMISIL Once 1 % CUTANEOUS SOLUTION and LAMISIL NCH 1 % CUTANEOUS SOLUTION (PL 00030/0213-4).
INTRODUCTION Based on the review of the data on quality, safety and efficacy the UK granted marketing authorisations for the medicinal products Lamisil Once 1 % Cutaneous
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: